Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374930 | Bioorganic & Medicinal Chemistry Letters | 2006 | 6 Pages |
Abstract
In a high-throughput screening effort, a series of tetrahydroisoquinolines was identified as modest inhibitors of human Eg5. A medicinal chemistry optimization effort led to the identification of R-4-(3-hydroxyphenyl)-N,N-7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide (32a) as a potent inhibitor of human Eg5 (ATPase IC50 104 nM) with good anti-proliferative activity in A2780 cells (IC50 234 nM).
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Christine M. Tarby, Robert F. Kaltenbach III, Tram Huynh, Andrew Pudzianowski, Henry Shen, Marie Ortega-Nanos, Steven Sheriff, John A. Newitt, Patricia A. McDonnell, Neil Burford, Craig R. Fairchild, Wayne Vaccaro, Zhong Chen, Robert M. Borzilleri,